{"abstract": "The drug maker said it would delay seeking approval for an experimental osteoporosis drug, an announcement that helped send the company\u2019s shares down 3 percent.", "web_url": "https://www.nytimes.com/2013/02/02/business/merck-delays-osteoporosis-drug.html", "snippet": "The drug maker said it would delay seeking approval for an experimental osteoporosis drug, an announcement that helped send the company\u2019s shares down 3 percent.", "lead_paragraph": "Merck said on Friday that it would delay seeking approval for an experimental osteoporosis drug, an announcement that helped send the company\u2019s shares down 3 percent on the same day it announced its fourth-quarter earnings for 2012.", "print_section": "B", "print_page": "2", "source": "The New York Times", "multimedia": [], "headline": {"main": "Merck Delays Osteoporosis Drug", "kicker": null, "content_kicker": null, "print_headline": "Merck Delays Application for Osteoporosis Drug", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "persons", "value": "Thomas, Katie", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Merck & Company Inc", "rank": 2, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 3, "major": "N"}, {"name": "subject", "value": "Clinical Trials", "rank": 4, "major": "N"}, {"name": "subject", "value": "Osteoporosis", "rank": 5, "major": "N"}], "pub_date": "2013-02-01T19:34:28+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Katie Thomas", "person": [{"firstname": "Katie", "middlename": null, "lastname": "Thomas", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/031f048b-ff58-5287-b15a-2f388b3724fc", "word_count": 370, "uri": "nyt://article/031f048b-ff58-5287-b15a-2f388b3724fc"}